Shareprice
16 Jan 2025

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

Roger Gunnarsson resigns as board member due to return to a full-time investment banking career, which precludes him from holding board position in FluoGuide

News


October 21, 2024

Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in precision cancer surgery, announces that Roger Gunnarsson will resign from his position as member of the board of directors in FluoGuide, effective 31 October 2023.

Roger returns to his previous career in healthcare investment banking. Due to the demand of his new, full-time position, he is required to step down as board of director in FluoGuide.

“Roger’s commitment and expertise have been invaluable, particularly in respect of partnering structures, and although his short service his participation was probably the most important point in time for FluoGuide,” said Peter Mørch Eriksen, Chairman of the board of directors of FluoGuide, and continues “We wish him all the best in his new role.”

The Board will not replace Roger for now but will review the Board composition during the annual nomination committee process.